An early phase manufacturer developed an innovative medical device and was rapidly gaining market traction and generating impressive sales. Facing the growth of bundled and capitated payment plans, the company engaged Numerof to develop a compelling economic and clinical effectiveness case to support product sales, and improve the company’s valuation and attractiveness as an investment.

Read More

Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.

Privacy is important. We do not share registrant information with anyone outside of Numerof & Associates. For details, please see our Privacy Policy. Subscribers to our mailings can unsubscribe instantly at any time.

×